We read with interest the article entitled “The Role of Systemic Immune Inflammation Index for Predicting Saphenous Vein Graft Disease in Patients with Coronary Artery Bypass Grafting.” We congratulate the authors for their contribution. We would like to discuss some points about the late development of saphenous vein graft disease.
DogdusMDindasFYenercagM, et al.The Role of Systemic Immune Inflammation Index for Predicting Saphenous Vein Graft Disease in Patients with Coronary Artery Bypass Grafting. Angiology2023;74:579-586.
2.
WardAOCaputoMAngeliniGDGeorgeSJZakkarM. Activation and inflammation of the venous endothelium in vein graft disease. Atherosclerosis2017;265:266‐274.
3.
de VriesMRSimonsKHJukemaJWBraunJQuaxPH. Vein graft failure: from pathophysiology to clinical outcomes. Nat Rev Cardiol2016;13:451‐470.
4.
WangWZhangYWangL, et al.mircroRNA-152 prevents the malignant progression of atherosclerosis via downregulation of KLF5. Biomed Pharmacother2019;109:2409‐2414.
5.
WardAOAngeliniGDCaputoM, et al.NF-κB inhibition prevents acute shear stress-induced inflammation in the saphenous vein graft endothelium. Sci Rep2020;10:15133.
6.
CandemirMKiziltunçENurkoçSŞahinarslanA. Relationship Between Systemic Immune-Inflammation Index (SII) and the Severity of Stable Coronary Artery Disease. Angiology2021;72:575‐581.
7.
GuidaGAAngeliniGD. Pathophysiology and Mechanisms of Saphenous Vein Graft Failure. Braz J Cardiovasc Surg2022; 37(Special 1):32‐37.
8.
XenogiannisIZenatiMBhattDL, et al.Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies. Circulation2021;144:728‐745.
